Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study

BACKGROUND: Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are limited for posaconazole IV and delayed-release tablet formu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Clin Microbiol Antimicrob
Asıl Yazarlar: Yi, Whitley M., Schoeppler, Kelly E., Jaeger, Jaclyn, Mueller, Scott W., MacLaren, Robert, Fish, Douglas N., Kiser, Tyree H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5594434/
https://ncbi.nlm.nih.gov/pubmed/28893246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-017-0235-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller